| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d4ad61d0af1fd483d31d1c5df9b9b76 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2018-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_041c50def589170e9c1790eb16151524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5db4f035e7a4f862021b8adf236927a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6960ef52ace51fe1f7319c9bd3d98f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69deef6ca701f6a629b3efb12abe2551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af6f42daac95d709e556eb920480a8b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_179d06b7beb693c14d984b16ad374c27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65aec68a67644c70b0574899075973f |
| publicationDate |
2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200033069-A |
| titleOfInvention |
Composition For Enhancing Sensitivity for Anti-Cancer Drug Comprising NecroX Compound |
| abstract |
The present invention relates to a novel use of the necrox compound to enhance the sensitivity of tumors to anticancer agents. Enhancement of susceptibility to the anticancer agent of the necrox compound in the present invention is particularly pronounced in Epstein-Barr virus (EBV) -positive cancer. In the present invention, the necrox compound may be usefully used as an active ingredient in a pharmaceutical composition and a food composition for adjuvant anticancer agents for enhancing susceptibility to cancer cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023182840-A1 |
| priorityDate |
2018-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |